Grand Pharmaceutical Group Limited(HK:0512)
HK$4.32-0.02 (-0.58%)
HK:0512
Grand Pharmaceutical Group Limited financials statements
HK$4.32
At close:-0.02 (-0.58%)
Want to see HK:0512 full AI Analyst Report?
Grand Pharmaceutical Group Limited (0512) Income Statement
5 Followers
Grand Pharmaceutical Group Limited Income Statement
Last quarter (Q2 2026), Grand Pharmaceutical Group Limited's total revenue was HK$6.39B, an increase of 5.65% from the same quarter last year. In Q2, Grand Pharmaceutical Group Limited's net income was HK$1.06B. See Grand Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| HK$ 12.28B | HK$ 11.64B | HK$ 10.53B | HK$ 9.56B | HK$ 8.60B | |
| HK$ 6.78B | HK$ 6.74B | HK$ 6.52B | HK$ 5.95B | HK$ 5.25B | |
| HK$ 5.74B | HK$ 4.57B | HK$ 3.86B | HK$ 3.43B | HK$ 3.23B | |
| Depreciation and Amortization | HK$ 581.89M | HK$ 503.75M | HK$ 392.21M | HK$ 394.91M | HK$ 339.52M |
| HK$ 2.35B | HK$ 3.39B | HK$ 2.97B | HK$ 3.09B | HK$ 3.10B | |
| HK$ 1.04B | HK$ 2.17B | HK$ 2.66B | HK$ 2.52B | HK$ 2.02B | |
| HK$ 451.59M | HK$ 680.33M | HK$ -319.20M | HK$ -731.00K | HK$ 767.25M | |
| HK$ 1.49B | HK$ 2.85B | HK$ 2.34B | HK$ 2.52B | HK$ 2.79B | |
| HK$ 1.24B | HK$ 2.47B | HK$ 1.88B | HK$ 2.08B | HK$ 2.40B | |
| Per Share Metrics | |||||
| Basic EPS | HK$ 0.35 | HK$ 0.70 | HK$ 0.54 | HK$ 0.59 | HK$ 0.68 |
| Diluted EPS | HK$ 0.35 | HK$ 0.70 | HK$ 0.54 | HK$ 0.59 | HK$ 0.68 |
| Weighted Average Shares Outstanding | 3.50B | 3.50B | 3.51B | 3.54B | 3.55B |
| Weighted Average Shares Outstanding (Diluted) | 3.50B | 3.50B | 3.51B | 3.54B | 3.55B |
Currency in HKD

